Medications for Thyroid Cancer
- Liothyronine—used postoperatively to prepare for radioiodine scan
- Thyrotropin alfa—a synthetic thryoid stimulating hormone (TSH) used to prepare for scanning or for thyroglobulin blood level measurement
- You may notice a skin rash within the first few months of treatment with thyroid hormone.
- You may lose more hair than usual within the first few months of treatment with thyroid hormone.
- Levothyroxine or liothyronine may causes symptoms similar to overactive thyroid including rapid heart rate, insomnia , weight loss, sweating, flusing in the face, or diarrhea .
- Thyrotropin alfa often causes nausea, muscle weakness, or headache.
- Weight gain
- Cold intolerance (you constantly feel chilly when others are comfortable)
- Dry skin
- Dry hair
- Low energy
- Muscle or joint pains
- Weight loss
- Feeling overheated, sweaty
- Abdominal cramps
- Chest pain
- Feeling jittery or “hyper”
Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol. 2007;8:148-56
Conn’s Current Therapy. 54th ed. Philadelphia,PA: WB Saunders Company; 2002: 652-657.
Cooper DS, Doherty GM, Haugen BR, et al: The American Thyroid Association Guidelines Taskforce: management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:1-33.
Cornett WR, Sharma AK, Day TA, et al. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep. 2007;9:152-158.
Rachmiel M, Charron M, Gupta A, et al. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab. 2006;19:1377-1393.
Thyroid carcinoma. In: Cecil Textbook of Medicine. 21st ed. Philadelphia, PA: WB Saunders Company; 2000: 1247-1250.
What is thyroid cancer. American Cancer Society website. Available at http://www.cancer.org/docroot/CRI/CRI%5F2%5F3x.asp?dt=43 . Accessed December 10, 2002.
What you need to know about cancer of the thyroid. National Cancer Institute website. Available at http://cancer.gov/ . Accessed December 10, 2002.
- Reviewer: Igor Puzanov, MD
- Review Date: 09/2012
- Update Date: 00/92/2012